2023-04-27 10:07:00 ET
The pharmaceutical industry is among the most profitable in the entire investment universe. This is because drug patents give drugmakers practical monopolies for long periods of time before those patents expire and competition is allowed by regulators.
But that's not to say that the pharmaceutical industry is without its risks. Companies need to consistently launch new drugs to keep large and growing cash flows coming. Consider, for example, Switerland-based Novartis (NYSE: NVS) . It's one of the largest drugmakers in the world, but can it continue turning out great products and rewarding investors?
Let's examine Novartis' fundamentals and valuation to decide.
For further details see:
Is This Big Pharma Stock a Buy for Dividend Investors?